Clinical significance of circulating tumor cells in predicting disease progression and chemotherapy resistance in patients with gestational choriocarcinoma-Reference-Cited by-同舟云学术

Clinical significance of circulating tumor cells in predicting disease progression and chemotherapy resistance in patients with gestational choriocarcinoma

Published:2018-10-26 Issue:6 Volume:144 Page:1421-1431
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

He Weiling¹²,Hou Minzhi³⁴,Zhang Hui²,Zeng Chao¹⁵,He Shanyang³,Chen Xinlin⁶^ORCID,Xu Manman³,Sun Cong¹,Jiang Wenting¹,Wang Han¹,Shen Hongwei³,Zhang Yang⁷,Liu Jing⁸,Sun Shijun⁹,Jiang Neng¹,Cui Yongmei¹,Sun Yu¹,Chen Yangshan¹,Cao Jessica¹⁰,Wang Chunlin¹¹,Li Mengzhen¹²,Zhang Yi¹³,Wang Liantang¹,Wang Jianhong¹⁴,Lin Millicent¹⁵,Ke Zunfu¹^ORCID

Affiliation:

1. Department of Pathology, The First Affiliated Hospital; Sun Yat-Sen University; Guangzhou Guangdong People's Republic of China

2. Institute of Precision Medicine, The First Affiliated Hospital; Sun Yat-Sen University; Guangzhou Guangdong People's Republic of China

3. Department of Gynecology, The First Affiliated Hospital; Sun Yat-Sen University; Guangzhou Guangdong People's Republic of China

4. Department of Gynecology, Sun Yat-Sen Memorial Hospital; Sun Yat-Sen University; Guangzhou Guangdong People's Republic of China

5. Department of Pathology; Guangdong Medical College; Dongguan Guangdong People's Republic of China

6. School of Basic Medical Science; Guangzhou University of Chinese Medicine; Guangzhou Guangdong People's Republic of China

7. Biomedical Engineering; The University of Texas at El Paso; El Paso TX

8. Department of Anesthesiology; Guangdong Women and Children Hospital; Guangzhou Guangdong People's Republic of China

9. Molecular Diagnosis Center, The Affiliated Zhongshan Hospital; Sun Yat-Sen University; Zhongshan Guangdong People's Republic of China

10. Cumming School of Medicine; University of Calgary; Calgary AB Canada

11. Chapter Diagnostics; Menlo Park CA

12. MyGene Diagnostics; Guangzhou International Biotech Island; Guangdong People's Republic of China

13. Biomedical Imaging Research Institute; Cedars-Sinai Medical Center; Los Angeles CA

14. Pricision Medicine Center; Shenzhen People's Hospital; Shenzhen Guangdong People's Republic of China

15. Department of Genetics; Harvard Medical School; Boston MA

Funder

Guangzhou and Guangdong/Guangzhou Science and Technology Planning Program

Natural Science Foundation of Guangdong Province

National Natural Science Foundation of China

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/ijc.31742/fullpdf

Reference51 articles.

1. Choriocarcinoma and partial hydatidiform moles;Seckl;Lancet,2000

2. Gestational trophoblastic disease: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up;Seckl;Ann Oncol,2013

3. Prognostic markers and long-term outcome of placental-site trophoblastic tumours: a retrospective observational study;Schmid;Lancet,2009

4. Clinical observations on chemotherapy curable malignancies: unique genetic events, frozen development and enduring apoptotic potential;Savage;BMC cancer,2015

5. Gestational trophoblastic neoplasia: treatment outcomes from a single institutional experience;Al-Husaini;Clin Transl Oncol,2015

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Establishment and characterization of a non-gestational choriocarcinoma patient-derived xenograft model;BMC Cancer;2023-11-13

2. A narrative review of diagnostic and therapeutic potential of isolation ofcirculating tumor cells;Український радіологічний та онкологічний журнал;2023-03-30

3. Detection of circulating tumor cells: opportunities and challenges;Biomarker Research;2022-08-13

4. Circulating Tumour Cells Indicate the Presence of Residual Disease Post-Castration in Prostate Cancer Patient-Derived Xenograft Models;Frontiers in Cell and Developmental Biology;2022-04-13

5. Progression of Exosome-Mediated Chemotherapy Resistance in Cancer;Oncologie;2022